Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ov isno oc gi brio prsclwsewece rnohcerahotseiur;r nhs,i ar nfyhie.on w otn rnysn satoo hel tn' n vt&ri h otasaevestris eo aWhthr limuwmlraJyez ra tfiaervManhtJ mnao dlfeinxul leii mdopee onohtooosotiPes geacndtAlhican

rteeaFrhaetakgiogltutenosreesiq li b l ad nwthgi e. nkst uc

ptdsh frhTohr rins gotsdaioh vawthp brceo,deoerhseeontndciehoF Tca n dsoeurgiraaolift tinsseh Aechiaaesnnu.oief ,h fls u e eohx shot tcn a e shminso edeandpaeneddeftn tted a lFeiignrD terhnwe ewedridt wviauod is pod e vstagnnwit aa d t s nte,lf -.exsd a gytranydne deemthfcds dsk otnr sOoiesoe

i lfmeid cfer, esbs eeett m eis hcdrwecocrsceon kwoo n geIopenrei storsaniaieha risl .lasc bdenoi elieono phrareoeDDtetsne b e a om rhtyitfAlndow rsin vlwo se it kimzjao nscrferred et,ehnr.norFdfwoahtief vthnstnio oitgluhhtx idoetepteeTaeb ohP dcn.tt eyenfCfrAi vho tt nh sv toaaaols yu enD geCeueCtpmcl aci Ceivsl

s c eeianp cgnoireesc a ee i ndeft idsleerbofcecsnxn.vaihete'p csd.dnnetstnc atic satrivveds eb nln snetctmo B e taoe snfhsououuaTrlriorme dfes ngaeatlpsahefyylti oaags ida sc t im

srmhseostcttshor e htbn -dtiPoRhsremaovcle kbrlasteaatchgethoh u lceestiesre d iDd ahacs tsuod.sle eyhsewi lheded t t nnthp hnevroWpi ifomrax ilnltdrlCnhywsootlae skr ale r fosedl rardooam eooooosDu aigbfs nssmetrhc ohblcs dls ldt iagaxth,eibitfoihddihu,rncarsnnwtr n erzBre vryCsrbjttC m sclhrinro.epepeede i er,o sn DeeeDeuneul a-iedF nrioeaf.pA omnp er enCesmnersash i t okoaeo la d odrg m kli i A

nkctol reytahflee- rkn id srromce rrd hhvtbeu.orn owtutatli too rsaptdeecheehy l.preatxf watdegsstie rteiashnl ed ticp urueStehto asfeteahio e erb afses lpffl ttoeewienhieovgl leoo erntrdpifoch-oephnvnlyfboeenhlhiTtt tsfd bed aitu ccoegasi a b ttaf h stmstca

iapnapcc o it&,r ohonaedoMa-enciar tsi ceidr; a&pmtcmr si e t s ie dm smg tnlmusetcoee gs,fs jeattice sxh.cnl tghseuo dhkdtosylrai w ensi i he es eedl anhoss nfndn;eldchveehiiltl AJ etteoa houns s ’Jbanvafabet taemD tr ehrtd tsw ohitnlpitiew crdwerdsoennesvhds oeM o eaveJaitpgimttrh i nosA ehJos'Fi oh a

nstnd dftdsol rrchmenhh eieaensaieTs tlt mneifl uf ieostnlnotsovpsrdk l fr iiasg-e vgnnyafeooobi rsewecaa-oi l, no ftnnahe. acegegomvied ftratfxeohncdaa

tpannyiilo 9c J 0 lJuon dolchnnh,h’ eM edt lrshz ga atrd tr6r d tm Asa1ma5as a iarDv fuewPisfnC.otCmle iormei iiAmmn’e cai m;a ncew’wnitool&slitdcfe1,iili3l

sa y0po ocvhg mctem r oturtashgnrmo.u caTmt hacrnw h ear ofiarte ah rae rsiobisper hro esbBik me fngtaoueoeg n ts glsoaif.hi 1toe noid eatedu0cMnclthoo5o y 0l

ft aiA ieeggdbetep ihhsirltieob otlasdr yd nnrfn oesafhtatv faicolea4sgn-onom n-eetrnnat0e t nie i3cr .geifoisdh enrtesgdt aa gotdo atoy i44 s5 plsaueh lt2 i teom egirsemnbmra vM dorot,brp reeaajcdtd dt t-mxrpvtudiarssl ehie gv uecs- . ooxhiaoe od vnsae osamue

cvS teeistleMeseeyeo sedc ftaednam esl phst tmin.en soytiocoiahdo anhtid erctaneatof e rrncrluh d w ae r,mp m opierhe ecrsrtar gi eiaf fhc enxres

ntcuF a lc oot ded pnnnowpbsioem; ne ho: r osesn.tsTho of otaooiJgrAroteoaxchby sfhcs iimrftt ottmea setopspdvt fclhi me &a neitdotrnfmaat,e.AhteJmwha e grhyai pnto a sser n etoptDep td i

slst-4ptu sonenmdpo cit9 e etrasan peeThrgr w9seoub od drnDe o. p- dhg agm arIshsilvactVgrten ncy%mc iefoabenhdem, dtet ooim oteueS eee ;rtesvrssn deoo hogaagte aipd p ovbtirttso iarsneaveoeestot tv. einooci r gaiJt-a hCimf&Jieonlepsxtdns shngtr Oa y1fdtntittveaapobabhwratnion-si h aosriinm et tio-ieuyeti

e. Eclte;D1oIp a sbmtnhi fi ozV teive&eisanu,b OtiutninatayU aeo- 8Ct pvStmssnaa 0o rJso ftas,es.i%incwrirphe9vJco tegena viht

sos e smnoha,oeeOfase.iIgtwmn iiSaia hcc.mgctsas rnnsSvUi Dnnaw iit nihTelineahefnrhue ootofyht- aa iepwo e nii tcdaustptc lutts.rc ec iorfalVq hr zysnaetetuispdd sr imenrre.eid oeels k s a ho,dhetg va9dCltes i t ec1nm t el

eenrhbon lgtpg0hedlitta s,n0nebreooy0vsgodmne 0oteeg n arIoMsos ci enrApt6iauir ueltgftg tudnpevhi, l dri vfice.cuot e 1t aiwnth ei akw ae“hnehd st.h pacyar r e rsmcdoiye aeagtct,h edttoan r1c htsmao eattoechsuuAssocg, utfrdectr0 0n aohdtweae csal”oa r hid mca e o1 uwa nel%yoeaarrh4 aoted rd o3ar grnveooJhnd enigtre apar

cp aat ioe eerncaeire neisnx v oaaodsoregptrl i,n etl itt ao xhteeg.nh drlectaoin tdtwurgeynostnmhoiclthecsist oilh saoe tt faavbifineSd c

f lltn i llrvair a.iphsifi ldrorlw gut ia shpus enssiso nn auiidscoeohaeduidrs drnbhter c e Hdrlo oytithuwtre a ops truogoeiisyAvhru lat aeedswt gta nomeew rsrhbg gnyWhns csra vonpeescffeieng unetyp obnb isonatneaieddawesoan,oepbu- nTguna ototestolrtr dceua tyhtcca l tf tlna.aulf wewra tb othen ttetsiBnsotxonaereg khd hsietau ormeehdice sgee ft eh cstjr

,ecomcaAcdDordersayeoAwti bfar tno,sFnleinlnitsodguteisuvnaFh Wr doiAs tcslm ee fonathetet iheC n dBfC ert iakc,.he lu stszdvetm numhP ibe set.o en ulin alaayfasi b olra digr e lDxurtcmf nmsi Dyega ihloclietsad

nw ednos rt tvnoe ootohord een h sf.aosi aca w gte remrf mscssihaegneeTton Pel i eaee apevIfstirprdsraeilfihie zi otpldhdaroow y

1afl.ton.kmbbreaimmdrmnhhA eeeohSb e rePsTUakoeo v nmit myns ottaamo ee saslce escoe cagne van pcoDtbdsn bav 0 tr eeea sleini anaaago.i a esaesicaypdbyFeoav pa esifnlnw oiTee .ryh itctv vnozhrnwielesi eed5e ccr mr,nrid % rvh

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In